1. In a phase II trial, brepocitinib improved cutaneous sarcoidosis disease activity rapidly compared to placebo, with dose -ependent treatment effects demonstrated across increasingly rigorous responder- and remission-oriented endpoints. 2....
In Amgen-reported phase 3 results, dazodalibep reduced systemic disease activity versus placebo in patients with Sjögren's disease.
The FDA did not approve Optune Mya for brain metastases from non-small cell lung cancer, citing uncertainty about clinical benefit without safety concerns.
The American Cancer Society recommends regular PSA-based screening for average-risk men aged 50 to 69 and earlier, more frequent screening for higher-risk men.
2MM+ membership
View full plan →Pay yearly and get 2 months free.
Then $4.99/month. Manage renewal from your account.
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
1. The EAST-AFNET 4 trial (East AF) demonstrated that early rhythm control therapy—including antiarrhythmic drugs or catheter ablation—was associated...
1. Lesions observed in mammography with spiculated margins, linear calcification morphology, irregular shape, segmental calcification distribution, or linear calcification...
1. Thrombectomy performed between 6 and 24 hours after onset of acute stroke in patients with a mismatch between...
1. The Ottawa ankle rules significantly reduced referral for ankle, but not foot, radiography in the emergency department. 2....
3-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
3-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free
Then $49.90/year.
Already a member? Sign in